Report title: Neurologic, Inc. - Portfolio Company Report
from Thomson Financial Venture Economics
published May 16, 2009

Price $24.00 available for immediate download
Report Overview
 
About Thomson Financial Venture Econ...

Provides solutions for central nervous system disorders and diseases affecting attention, learning and memory disorders such as Alzheimer's disease. The Company develops therapeutics for learning and memory disorders. The Company integrates molecular, genomic, biophysical and diagnostic techniques for the treatment of neurological disorders. ; Provides solutions for central nervous system disorders.

Report Type: This research report shows venture capital financing information for this specific company.
Executives Listed: 2
Number of Investing Funds: 2
Free Sample: Click Here to Download
Format:
PDF Adobe Acrobat


Price: $24.00



  Can't Decide?

Purchasing premium research sight unseen can be intimidating. At Alacra we want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.